Julie Schmittdiel to Hypertension
This is a "connection" page, showing publications Julie Schmittdiel has written about Hypertension.
Connection Strength
2.267
-
Comorbid Diabetes and Severe Mental Illness: Outcomes in an Integrated Health Care Delivery System. J Gen Intern Med. 2020 01; 35(1):160-166.
Score: 0.488
-
Initial persistence with antihypertensive therapies is associated with depression treatment persistence, but not depression. J Clin Hypertens (Greenwich). 2014 Jun; 16(6):412-7.
Score: 0.332
-
Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users. JAMA Intern Med. 2013 Jan 14; 173(1):54-61.
Score: 0.304
-
Missed opportunities in cardiovascular disease prevention?: low rates of hypertension recognition for women at medicine and obstetrics-gynecology clinics. Hypertension. 2011 Apr; 57(4):717-22.
Score: 0.267
-
Characteristics of diabetic patients associated with achieving and maintaining blood pressure targets in the Adherence and Intensification of Medications program. Chronic Illn. 2014 Mar; 10(1):60-73.
Score: 0.079
-
Detection and recognition of hypertension in anxious and depressed patients. J Hypertens. 2012 Dec; 30(12):2293-8.
Score: 0.075
-
Benefits of early hypertension control on cardiovascular outcomes in patients with diabetes. Diabetes Care. 2013 Feb; 36(2):322-7.
Score: 0.074
-
The association between medication adherence and treatment intensification with blood pressure control in resistant hypertension. Hypertension. 2012 Aug; 60(2):303-9.
Score: 0.073
-
A comparison between antihypertensive medication adherence and treatment intensification as potential clinical performance measures. Circ Cardiovasc Qual Outcomes. 2012 May; 5(3):276-82.
Score: 0.073
-
Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial. Circulation. 2012 Jun 12; 125(23):2863-72.
Score: 0.073
-
Age-dependent gender differences in hypertension management. J Hypertens. 2011 May; 29(5):1005-11.
Score: 0.068
-
Study protocol: the Adherence and Intensification of Medications (AIM) study--a cluster randomized controlled effectiveness study. Trials. 2010 Oct 12; 11:95.
Score: 0.065
-
Trends in time to confirmation and recognition of new-onset hypertension, 2002-2006. Hypertension. 2010 Oct; 56(4):605-11.
Score: 0.064
-
The association of patient-physician gender concordance with cardiovascular disease risk factor control and treatment in diabetes. J Womens Health (Larchmt). 2009 Dec; 18(12):2065-70.
Score: 0.061
-
When more is not better: treatment intensification among hypertensive patients with poor medication adherence. Circulation. 2008 Jun 03; 117(22):2884-92.
Score: 0.055
-
Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med. 2008 May; 23(5):588-94.
Score: 0.054
-
The impact of removing financial incentives from clinical quality indicators: longitudinal analysis of four Kaiser Permanente indicators. BMJ. 2010 May 11; 340:c1898.
Score: 0.016
-
Meaningful variation in performance: what does variation in quality tell us about improving quality? Med Care. 2010 Feb; 48(2):133-9.
Score: 0.016
-
New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. Health Serv Res. 2009 Oct; 44(5 Pt 1):1640-61.
Score: 0.015
-
Treatment intensification and risk factor control: toward more clinically relevant quality measures. Med Care. 2009 Apr; 47(4):395-402.
Score: 0.015